 | • レポートコード：QFJ1-4023 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、臨床バイオマーカー検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（がん、代謝、感染症、循環器、神経、免疫疾患）、用途別市場規模（創薬、ニュートリゲノミクス、毒物学検査、個別化医療、機能ゲノミクス）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・臨床バイオマーカー検査の市場動向 ・企業の競争状況、市場シェア ・臨床バイオマーカー検査の種類別市場規模と予測2016-2027（がん、代謝、感染症、循環器、神経、免疫疾患） ・臨床バイオマーカー検査の用途別市場規模と予測2016-2027（創薬、ニュートリゲノミクス、毒物学検査、個別化医療、機能ゲノミクス） ・臨床バイオマーカー検査の北米市場規模2016-2027（アメリカ、カナダ） ・臨床バイオマーカー検査の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・臨床バイオマーカー検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・臨床バイオマーカー検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・臨床バイオマーカー検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、AbbVie Inc.、Adaptive Biotechnologies、Agilent Technologies、BD、Becton Dickinson、Bio-Rad Laboratories、Danaher Corporation、Merck and Co.、Thermofisher Scientific） ・結論 |
Biomarker testing is a group of tests that looks for these molecular signs of health so that doctors can plan the best care during the clinic treatment.
Biomarker testing is a group of tests that looks for these molecular signs of health so that doctors can plan the best care during the clinic treatment.
Market Analysis and Insights: Global Clinical Biomarker Testing Market
The global Clinical Biomarker Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Clinical Biomarker Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Clinical Biomarker Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Clinical Biomarker Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Clinical Biomarker Testing market.
Global Clinical Biomarker Testing Scope and Market Size
Clinical Biomarker Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Clinical Biomarker Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Cancer
Metabolism
Infectious Disease
Cardiology
Neurology
Immunological Disease
Segment by Application
Drug Discovery
Nutrigenomics
Toxicology Testing
Personalized Medicine
Functional Genomics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
AbbVie Inc.
Adaptive Biotechnologies
Agilent Technologies
BD
Becton Dickinson
Bio-Rad Laboratories
Danaher Corporation
Merck and Co.
Thermofisher Scientific
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Biomarker Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cancer
1.2.3 Metabolism
1.2.4 Infectious Disease
1.2.5 Cardiology
1.2.6 Neurology
1.2.7 Immunological Disease
1.3 Market by Application
1.3.1 Global Clinical Biomarker Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Drug Discovery
1.3.3 Nutrigenomics
1.3.4 Toxicology Testing
1.3.5 Personalized Medicine
1.3.6 Functional Genomics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Clinical Biomarker Testing Market Perspective (2016-2027)
2.2 Clinical Biomarker Testing Growth Trends by Regions
2.2.1 Clinical Biomarker Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Clinical Biomarker Testing Historic Market Share by Regions (2016-2021)
2.2.3 Clinical Biomarker Testing Forecasted Market Size by Regions (2022-2027)
2.3 Clinical Biomarker Testing Industry Dynamic
2.3.1 Clinical Biomarker Testing Market Trends
2.3.2 Clinical Biomarker Testing Market Drivers
2.3.3 Clinical Biomarker Testing Market Challenges
2.3.4 Clinical Biomarker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Biomarker Testing Players by Revenue
3.1.1 Global Top Clinical Biomarker Testing Players by Revenue (2016-2021)
3.1.2 Global Clinical Biomarker Testing Revenue Market Share by Players (2016-2021)
3.2 Global Clinical Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Clinical Biomarker Testing Revenue
3.4 Global Clinical Biomarker Testing Market Concentration Ratio
3.4.1 Global Clinical Biomarker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Biomarker Testing Revenue in 2020
3.5 Clinical Biomarker Testing Key Players Head office and Area Served
3.6 Key Players Clinical Biomarker Testing Product Solution and Service
3.7 Date of Enter into Clinical Biomarker Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Biomarker Testing Breakdown Data by Type
4.1 Global Clinical Biomarker Testing Historic Market Size by Type (2016-2021)
4.2 Global Clinical Biomarker Testing Forecasted Market Size by Type (2022-2027)
5 Clinical Biomarker Testing Breakdown Data by Application
5.1 Global Clinical Biomarker Testing Historic Market Size by Application (2016-2021)
5.2 Global Clinical Biomarker Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Clinical Biomarker Testing Market Size (2016-2027)
6.2 North America Clinical Biomarker Testing Market Size by Type
6.2.1 North America Clinical Biomarker Testing Market Size by Type (2016-2021)
6.2.2 North America Clinical Biomarker Testing Market Size by Type (2022-2027)
6.2.3 North America Clinical Biomarker Testing Market Size by Type (2016-2027)
6.3 North America Clinical Biomarker Testing Market Size by Application
6.3.1 North America Clinical Biomarker Testing Market Size by Application (2016-2021)
6.3.2 North America Clinical Biomarker Testing Market Size by Application (2022-2027)
6.3.3 North America Clinical Biomarker Testing Market Size by Application (2016-2027)
6.4 North America Clinical Biomarker Testing Market Size by Country
6.4.1 North America Clinical Biomarker Testing Market Size by Country (2016-2021)
6.4.2 North America Clinical Biomarker Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Clinical Biomarker Testing Market Size (2016-2027)
7.2 Europe Clinical Biomarker Testing Market Size by Type
7.2.1 Europe Clinical Biomarker Testing Market Size by Type (2016-2021)
7.2.2 Europe Clinical Biomarker Testing Market Size by Type (2022-2027)
7.2.3 Europe Clinical Biomarker Testing Market Size by Type (2016-2027)
7.3 Europe Clinical Biomarker Testing Market Size by Application
7.3.1 Europe Clinical Biomarker Testing Market Size by Application (2016-2021)
7.3.2 Europe Clinical Biomarker Testing Market Size by Application (2022-2027)
7.3.3 Europe Clinical Biomarker Testing Market Size by Application (2016-2027)
7.4 Europe Clinical Biomarker Testing Market Size by Country
7.4.1 Europe Clinical Biomarker Testing Market Size by Country (2016-2021)
7.4.2 Europe Clinical Biomarker Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Clinical Biomarker Testing Market Size (2016-2027)
8.2 Asia-Pacific Clinical Biomarker Testing Market Size by Type
8.2.1 Asia-Pacific Clinical Biomarker Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Clinical Biomarker Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Clinical Biomarker Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Clinical Biomarker Testing Market Size by Application
8.3.1 Asia-Pacific Clinical Biomarker Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Clinical Biomarker Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Clinical Biomarker Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Clinical Biomarker Testing Market Size by Region
8.4.1 Asia-Pacific Clinical Biomarker Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Clinical Biomarker Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Clinical Biomarker Testing Market Size (2016-2027)
9.2 Latin America Clinical Biomarker Testing Market Size by Type
9.2.1 Latin America Clinical Biomarker Testing Market Size by Type (2016-2021)
9.2.2 Latin America Clinical Biomarker Testing Market Size by Type (2022-2027)
9.2.3 Latin America Clinical Biomarker Testing Market Size by Type (2016-2027)
9.3 Latin America Clinical Biomarker Testing Market Size by Application
9.3.1 Latin America Clinical Biomarker Testing Market Size by Application (2016-2021)
9.3.2 Latin America Clinical Biomarker Testing Market Size by Application (2022-2027)
9.3.3 Latin America Clinical Biomarker Testing Market Size by Application (2016-2027)
9.4 Latin America Clinical Biomarker Testing Market Size by Country
9.4.1 Latin America Clinical Biomarker Testing Market Size by Country (2016-2021)
9.4.2 Latin America Clinical Biomarker Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Biomarker Testing Market Size (2016-2027)
10.2 Middle East & Africa Clinical Biomarker Testing Market Size by Type
10.2.1 Middle East & Africa Clinical Biomarker Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Clinical Biomarker Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Clinical Biomarker Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Clinical Biomarker Testing Market Size by Application
10.3.1 Middle East & Africa Clinical Biomarker Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Clinical Biomarker Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Clinical Biomarker Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Clinical Biomarker Testing Market Size by Country
10.4.1 Middle East & Africa Clinical Biomarker Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Clinical Biomarker Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Clinical Biomarker Testing Introduction
11.1.4 Abbott Laboratories Revenue in Clinical Biomarker Testing Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 AbbVie Inc.
11.2.1 AbbVie Inc. Company Details
11.2.2 AbbVie Inc. Business Overview
11.2.3 AbbVie Inc. Clinical Biomarker Testing Introduction
11.2.4 AbbVie Inc. Revenue in Clinical Biomarker Testing Business (2016-2021)
11.2.5 AbbVie Inc. Recent Development
11.3 Adaptive Biotechnologies
11.3.1 Adaptive Biotechnologies Company Details
11.3.2 Adaptive Biotechnologies Business Overview
11.3.3 Adaptive Biotechnologies Clinical Biomarker Testing Introduction
11.3.4 Adaptive Biotechnologies Revenue in Clinical Biomarker Testing Business (2016-2021)
11.3.5 Adaptive Biotechnologies Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Clinical Biomarker Testing Introduction
11.4.4 Agilent Technologies Revenue in Clinical Biomarker Testing Business (2016-2021)
11.4.5 Agilent Technologies Recent Development
11.5 BD
11.5.1 BD Company Details
11.5.2 BD Business Overview
11.5.3 BD Clinical Biomarker Testing Introduction
11.5.4 BD Revenue in Clinical Biomarker Testing Business (2016-2021)
11.5.5 BD Recent Development
11.6 Becton Dickinson
11.6.1 Becton Dickinson Company Details
11.6.2 Becton Dickinson Business Overview
11.6.3 Becton Dickinson Clinical Biomarker Testing Introduction
11.6.4 Becton Dickinson Revenue in Clinical Biomarker Testing Business (2016-2021)
11.6.5 Becton Dickinson Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Clinical Biomarker Testing Introduction
11.7.4 Bio-Rad Laboratories Revenue in Clinical Biomarker Testing Business (2016-2021)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Details
11.8.2 Danaher Corporation Business Overview
11.8.3 Danaher Corporation Clinical Biomarker Testing Introduction
11.8.4 Danaher Corporation Revenue in Clinical Biomarker Testing Business (2016-2021)
11.8.5 Danaher Corporation Recent Development
11.9 Merck and Co.
11.9.1 Merck and Co. Company Details
11.9.2 Merck and Co. Business Overview
11.9.3 Merck and Co. Clinical Biomarker Testing Introduction
11.9.4 Merck and Co. Revenue in Clinical Biomarker Testing Business (2016-2021)
11.9.5 Merck and Co. Recent Development
11.10 Thermofisher Scientific
11.10.1 Thermofisher Scientific Company Details
11.10.2 Thermofisher Scientific Business Overview
11.10.3 Thermofisher Scientific Clinical Biomarker Testing Introduction
11.10.4 Thermofisher Scientific Revenue in Clinical Biomarker Testing Business (2016-2021)
11.10.5 Thermofisher Scientific Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Clinical Biomarker Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cancer
Table 3. Key Players of Metabolism
Table 4. Key Players of Infectious Disease
Table 5. Key Players of Cardiology
Table 6. Key Players of Neurology
Table 7. Key Players of Immunological Disease
Table 8. Global Clinical Biomarker Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Clinical Biomarker Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Clinical Biomarker Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Clinical Biomarker Testing Market Share by Regions (2016-2021)
Table 12. Global Clinical Biomarker Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Clinical Biomarker Testing Market Share by Regions (2022-2027)
Table 14. Clinical Biomarker Testing Market Trends
Table 15. Clinical Biomarker Testing Market Drivers
Table 16. Clinical Biomarker Testing Market Challenges
Table 17. Clinical Biomarker Testing Market Restraints
Table 18. Global Clinical Biomarker Testing Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Clinical Biomarker Testing Market Share by Players (2016-2021)
Table 20. Global Top Clinical Biomarker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clinical Biomarker Testing as of 2020)
Table 21. Ranking of Global Top Clinical Biomarker Testing Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Clinical Biomarker Testing Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Clinical Biomarker Testing Product Solution and Service
Table 25. Date of Enter into Clinical Biomarker Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Clinical Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Clinical Biomarker Testing Revenue Market Share by Type (2016-2021)
Table 29. Global Clinical Biomarker Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Clinical Biomarker Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Clinical Biomarker Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Clinical Biomarker Testing Revenue Market Share by Application (2016-2021)
Table 33. Global Clinical Biomarker Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Clinical Biomarker Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Clinical Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Clinical Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Clinical Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Clinical Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Clinical Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Clinical Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Clinical Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Clinical Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Clinical Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Clinical Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Clinical Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Clinical Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Clinical Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Clinical Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Clinical Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Clinical Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Clinical Biomarker Testing Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Clinical Biomarker Testing Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Clinical Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Clinical Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Clinical Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Clinical Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Clinical Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Clinical Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Clinical Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Clinical Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Clinical Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Clinical Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Clinical Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Clinical Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 65. Abbott Laboratories Company Details
Table 66. Abbott Laboratories Business Overview
Table 67. Abbott Laboratories Clinical Biomarker Testing Product
Table 68. Abbott Laboratories Revenue in Clinical Biomarker Testing Business (2016-2021) & (US$ Million)
Table 69. Abbott Laboratories Recent Development
Table 70. AbbVie Inc. Company Details
Table 71. AbbVie Inc. Business Overview
Table 72. AbbVie Inc. Clinical Biomarker Testing Product
Table 73. AbbVie Inc. Revenue in Clinical Biomarker Testing Business (2016-2021) & (US$ Million)
Table 74. AbbVie Inc. Recent Development
Table 75. Adaptive Biotechnologies Company Details
Table 76. Adaptive Biotechnologies Business Overview
Table 77. Adaptive Biotechnologies Clinical Biomarker Testing Product
Table 78. Adaptive Biotechnologies Revenue in Clinical Biomarker Testing Business (2016-2021) & (US$ Million)
Table 79. Adaptive Biotechnologies Recent Development
Table 80. Agilent Technologies Company Details
Table 81. Agilent Technologies Business Overview
Table 82. Agilent Technologies Clinical Biomarker Testing Product
Table 83. Agilent Technologies Revenue in Clinical Biomarker Testing Business (2016-2021) & (US$ Million)
Table 84. Agilent Technologies Recent Development
Table 85. BD Company Details
Table 86. BD Business Overview
Table 87. BD Clinical Biomarker Testing Product
Table 88. BD Revenue in Clinical Biomarker Testing Business (2016-2021) & (US$ Million)
Table 89. BD Recent Development
Table 90. Becton Dickinson Company Details
Table 91. Becton Dickinson Business Overview
Table 92. Becton Dickinson Clinical Biomarker Testing Product
Table 93. Becton Dickinson Revenue in Clinical Biomarker Testing Business (2016-2021) & (US$ Million)
Table 94. Becton Dickinson Recent Development
Table 95. Bio-Rad Laboratories Company Details
Table 96. Bio-Rad Laboratories Business Overview
Table 97. Bio-Rad Laboratories Clinical Biomarker Testing Product
Table 98. Bio-Rad Laboratories Revenue in Clinical Biomarker Testing Business (2016-2021) & (US$ Million)
Table 99. Bio-Rad Laboratories Recent Development
Table 100. Danaher Corporation Company Details
Table 101. Danaher Corporation Business Overview
Table 102. Danaher Corporation Revenue in Clinical Biomarker Testing Business (2016-2021) & (US$ Million)
Table 103. Danaher Corporation Recent Development
Table 104. Merck and Co. Company Details
Table 105. Merck and Co. Business Overview
Table 106. Merck and Co. Clinical Biomarker Testing Product
Table 107. Merck and Co. Revenue in Clinical Biomarker Testing Business (2016-2021) & (US$ Million)
Table 108. Merck and Co. Recent Development
Table 109. Thermofisher Scientific Company Details
Table 110. Thermofisher Scientific Business Overview
Table 111. Thermofisher Scientific Clinical Biomarker Testing Product
Table 112. Thermofisher Scientific Revenue in Clinical Biomarker Testing Business (2016-2021) & (US$ Million)
Table 113. Thermofisher Scientific Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Clinical Biomarker Testing Market Share by Type: 2020 VS 2027
Figure 2. Cancer Features
Figure 3. Metabolism Features
Figure 4. Infectious Disease Features
Figure 5. Cardiology Features
Figure 6. Neurology Features
Figure 7. Immunological Disease Features
Figure 8. Global Clinical Biomarker Testing Market Share by Application: 2020 VS 2027
Figure 9. Drug Discovery Case Studies
Figure 10. Nutrigenomics Case Studies
Figure 11. Toxicology Testing Case Studies
Figure 12. Personalized Medicine Case Studies
Figure 13. Functional Genomics Case Studies
Figure 14. Clinical Biomarker Testing Report Years Considered
Figure 15. Global Clinical Biomarker Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Clinical Biomarker Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Clinical Biomarker Testing Market Share by Regions: 2020 VS 2027
Figure 18. Global Clinical Biomarker Testing Market Share by Regions (2022-2027)
Figure 19. Global Clinical Biomarker Testing Market Share by Players in 2020
Figure 20. Global Top Clinical Biomarker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clinical Biomarker Testing as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Clinical Biomarker Testing Revenue in 2020
Figure 22. Global Clinical Biomarker Testing Revenue Market Share by Type (2016-2021)
Figure 23. Global Clinical Biomarker Testing Revenue Market Share by Type (2022-2027)
Figure 24. North America Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Clinical Biomarker Testing Market Share by Type (2016-2027)
Figure 26. North America Clinical Biomarker Testing Market Share by Application (2016-2027)
Figure 27. North America Clinical Biomarker Testing Market Share by Country (2016-2027)
Figure 28. United States Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Clinical Biomarker Testing Market Share by Type (2016-2027)
Figure 32. Europe Clinical Biomarker Testing Market Share by Application (2016-2027)
Figure 33. Europe Clinical Biomarker Testing Market Share by Country (2016-2027)
Figure 34. Germany Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Clinical Biomarker Testing Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Clinical Biomarker Testing Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Clinical Biomarker Testing Market Share by Region (2016-2027)
Figure 44. China Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Clinical Biomarker Testing Market Share by Type (2016-2027)
Figure 52. Latin America Clinical Biomarker Testing Market Share by Application (2016-2027)
Figure 53. Latin America Clinical Biomarker Testing Market Share by Country (2016-2027)
Figure 54. Mexico Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Clinical Biomarker Testing Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Clinical Biomarker Testing Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Clinical Biomarker Testing Market Share by Country (2016-2027)
Figure 60. Turkey Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Clinical Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Abbott Laboratories Revenue Growth Rate in Clinical Biomarker Testing Business (2016-2021)
Figure 64. AbbVie Inc. Revenue Growth Rate in Clinical Biomarker Testing Business (2016-2021)
Figure 65. Adaptive Biotechnologies Revenue Growth Rate in Clinical Biomarker Testing Business (2016-2021)
Figure 66. Agilent Technologies Revenue Growth Rate in Clinical Biomarker Testing Business (2016-2021)
Figure 67. BD Revenue Growth Rate in Clinical Biomarker Testing Business (2016-2021)
Figure 68. Becton Dickinson Revenue Growth Rate in Clinical Biomarker Testing Business (2016-2021)
Figure 69. Bio-Rad Laboratories Revenue Growth Rate in Clinical Biomarker Testing Business (2016-2021)
Figure 70. Danaher Corporation Revenue Growth Rate in Clinical Biomarker Testing Business (2016-2021)
Figure 71. Merck and Co. Revenue Growth Rate in Clinical Biomarker Testing Business (2016-2021)
Figure 72. Thermofisher Scientific Revenue Growth Rate in Clinical Biomarker Testing Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の薬力学的バイオマーカー試験市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pharmacodynamic Biomarker Testing Market The global Pharmacodynamic Biomarker Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high da…- 世界のPD-L1バイオマーカー検査市場規模・現状・予測（2021年-2027年） Immunotherapy has the power to manage immune system, recognize the cancer cell and fight against it. Our immune system has T- cell that fight against diseases, infections including cancer. The cancer cell represents the protein known as PD-L1 protein. The PD-L1 protein binds to the receptor on the T…
- 世界のニュートリゲノミクス検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Nutrigenomics Testing Market The global Nutrigenomics Testing market size is projected to reach US$ 588.2 million by 2027, from US$ 343.1 million in 2020, at a CAGR of 7.5% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the…
- 感染症検査機器のグローバル市場2021 Infectious Disease Testing Instrumentation is a kind of instrument to diagnose infectious disease, such as HIV, HCV, HBV, HAV, CMV, HPV and so on. In the last several years, China market of Infectious Disease Testing Instrumentation developed year by year, with an average growth rate of 17.36% for t…
- 世界の性感染症（STD）検査市場規模・現状・予測（2021年-2027年） Sexually Transmitted Disease (STD) Testing is a medical means of testing, prevention, and treatment of Sexually Transmitted Disease (STD). The need for tests that eliminate certain patient and provider barriers, which hamper routine screening, is rising. In line with this, vendors of the global STD …